Down-regulation of decorin, a transforming growth factor-beta modulator, is associated with scarless fetal wound healing.

PURPOSE Transforming growth factor beta (TGF-beta) bioactivity has been implicated as a potential regulator of the transition from scarless healing to scar formation in fetal wounds. Decorin is an extracellular matrix proteoglycan that regulates TGF-beta bioactivity and assists in collagen fibrillogenesis. To determine its role in scarless repair, the authors examined decorin expression in fetal fibroblasts, skin, and wounds. METHODS A single, full-thickness, 2-mm open wound was created on the dorsal surface of fetal rats at 16.5 days (E16) and 18.5 days (E18) gestational age (term, 21.5 days [E21]). Wounds were harvested at 24 and 72 hours (n = 12 wounds per time-point). Nonwounded fetal skin at E17, E19, and E21 was harvested for analysis of decorin expression during skin development and as controls for wounds. In addition, fetal (E14, E18) and adult dermal fibroblasts were cultured for in vitro analysis. Reduced-cycle, specific primer, reverse transcriptase polymerase chain reaction was performed to quantitate decorin expression. RESULTS Decorin expression increased rapidly with increasing gestational age in both fetal fibroblasts and skin. Expression was increased 22-fold in E18 fibroblasts (P <.002) and 300-fold in adult fibroblasts (P <.001) compared with E14 fibroblasts. In skin, expression increased 74% (P <.01) during the fetal wound healing transition period between E17 and E19. However, in E16 wounds (scarless), decorin expression decreased 59% (P <.006) at 24 hours and 45% (P <.02) at 72 hours. Decorin expression did not change in E18 (scar) wounds at 24 and 72 hours (P >.05). CONCLUSIONS Early gestation fetal fibroblasts and fetal skin express decorin at lower levels than late gestation fetal and adult fibroblasts and skin. Decorin expression is down-regulated in scarless (E16) compared with scar (E18) wounds. Thus, increased decorin expression is associated with both skin development and scar formation. Conversely, decreased decorin expression is associated with scarless repair.

[1]  Marc H. Hedrick,et al.  Confocal Microscopic Analysis of Scarless Repair in the Fetal Rat: Defining the Transition , 2002, Plastic and reconstructive surgery.

[2]  F. Maquart,et al.  Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu(2+). , 2000, The Journal of investigative dermatology.

[3]  M. Longaker,et al.  Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair. , 2000, The American journal of pathology.

[4]  G. Tromp,et al.  Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing. , 2000, The Journal of surgical research.

[5]  A. Ghahary,et al.  Delayed appearance of decorin in healing burn scars , 2000, Histopathology.

[6]  M. Berry,et al.  Decorin Attenuates Gliotic Scar Formation in the Rat Cerebral Hemisphere , 1999, Experimental Neurology.

[7]  M. Weller,et al.  Inhibition of experimental rat glioma growth by decorin gene transfer is associated with decreased microglial infiltration , 1999, Journal of Neuroimmunology.

[8]  I. Dixon,et al.  Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. , 1999, Journal of molecular and cellular cardiology.

[9]  S. Fujino,et al.  Role of transforming growth factor-beta1 and decorin in development of central fibrosis in pulmonary adenocarcinoma. , 1999, Human pathology.

[10]  B. Font,et al.  Structural requirements for fibromodulin binding to collagen and the control of type I collagen fibrillogenesis--critical roles for disulphide bonding and the C-terminal region. , 1998, European journal of biochemistry.

[11]  E. Schönherr,et al.  Differences in decorin and biglycan expression in patients with gastric ulcer healing. , 1997, Scandinavian journal of gastroenterology.

[12]  Z. Werb,et al.  Decorin regulates collagenase gene expression in fibroblasts adhering to vitronectin. , 1996, Matrix biology : journal of the International Society for Matrix Biology.

[13]  M. Longaker,et al.  Discussion: The Fetal Fibroblast: The Effector Cell of Scarless Fetal Skin Repair , 1995 .

[14]  H. Lorenz,et al.  Exogenous Transforming Growth Factor‐Beta Amplifies Its Own Expression and Induces Scar Formation in a Model of Human Fetal Skin Repair , 1995, Annals of surgery.

[15]  A. Ghahary,et al.  Immunohistochemical localization of the proteoglycans decorin, biglycan and versican and transforming growth factor‐β in human post‐burn hypertrophic and mature scars , 1995, Histopathology.

[16]  D. Foreman,et al.  Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. , 1995, Journal of cell science.

[17]  T Matsumoto,et al.  Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. , 1994, The Journal of biological chemistry.

[18]  E. Schönherr,et al.  Selective inactivity of TGF‐β/decorin complexes , 1994 .

[19]  E. Ruoslahti,et al.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. , 1994, The Biochemical journal.

[20]  M. Harrison,et al.  Fetal surgical therapy , 1994, The Lancet.

[21]  T. Sakou,et al.  Expression and distribution of transforming growth factor-beta and decorin during fracture healing. , 1994, In vivo.

[22]  T. Zimmermann,et al.  Spatial and temporal patterns of gene expression for the proteoglycans biglycan and decorin and for transforming growth factor‐β1 revealed by in situ hybridization during experimentally induced liver fibrosis in the rat , 1993, Hepatology.

[23]  M. Longaker,et al.  Fetal Wound Healing The Ontogeny of Scar Formation in the Non‐Human Primate , 1993, Annals of surgery.

[24]  A. Gressner,et al.  Biglycan and decorin gene expression in normal and fibrotic rat liver: Cellular localization and regulatory factors , 1992, Hepatology.

[25]  I. K. Cohen,et al.  Scarless wound healing in the mammalian fetus. , 1992, Surgery, gynecology & obstetrics.

[26]  S. Ihara,et al.  Ontogenetic transition of wound healing pattern in rat skin occurring at the fetal stage. , 1990, Development.

[27]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[28]  R. Spendlove,et al.  Studies in fetal wound healing: I. A factor in fetal serum that stimulates deposition of hyaluronic acid. , 1989, Journal of pediatric surgery.

[29]  D. Heinegård,et al.  Interaction of a 59-kDa connective tissue matrix protein with collagen I and collagen II. , 1989, The Journal of biological chemistry.

[30]  I. K. Cohen,et al.  Transforming growth factor beta (TGF-β) induces fibrosis in a fetal wound model , 1988 .

[31]  J. Trotter,et al.  The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. , 1987, Collagen and related research.

[32]  R. Diaco.  7 – Practical Considerations for the Design of Quantitative PCR Assays , 1995 .

[33]  T. Colby,et al.  Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. , 1994, American journal of respiratory and critical care medicine.

[34]  M. Longaker,et al.  Studies in fetal wound healing, VI. Second and early third trimester fetal wounds demonstrate rapid collagen deposition without scar formation. , 1990, Journal of pediatric surgery.

[35]  K. Pringle.  A reassessment of pregnancy staging. , 1988, Fetal therapy.